News – Page 1146 – Endpoints News

Ex-Mela chief Gulfo joins the list of would-be FDA commish candidates, color-coded drug approval plan in hand

9 years ago

A biotech billionaire grabs microcap GenVec and its gene vector tech in buyout

9 years ago

Women are gaining more board seats in biotech, but real change is happening at a snail's pace

9 years ago

An upstart immunotherapy biotech emerges from stealth mode with big love for Kendall Square

9 years ago

Banned from Twitter, Martin Shkreli whips up a new online tirade in response to a mocking dig from PhRMA chief

9 years ago

Facing a deepening political crisis, PhRMA launches a major counterattack against its legion of critics

9 years ago

Bizarre takeover bid is dropped; Merck KGaA in licensing pact with Domain

9 years ago

Struggling Marinus gets a bump out of a positive PhII snapshot

9 years ago

Deep in talks with J&J, Actelion’s flagship drug cruises past a pivotal trial failure

9 years ago

Ovid adds $26M to its coffers as Takeda deal closes, building a war chest for pipeline construction work

9 years ago

After repeated setbacks on the checkpoint front, Bristol-Myers scores a $625M payout from Merck to settle patent ...

9 years ago

Libertarian ideas on FDA deregulation threaten biotech; It's time for some real power to reform drug prices, ...

9 years ago

Pfizer signs up for match-making service; Investors tell Sanofi: Make a deal, now

9 years ago

How Takeda won a $5.2B bidding war — against itself

9 years ago

The FDA’s cautionary Hall of Shame: 22 ‘breakthrough’ drugs that suddenly crashed in PhIII

9 years ago

Francis Collins gets a reprieve, held over as NIH chief under Trump — for now

9 years ago

Bristol-Myers staggered by a stunning checkpoint setback, hands Merck a free pass on frontline lung cancer combo

9 years ago

Synergy bags an FDA OK for constipation therapy Trulance in the lead up to an sNDA

9 years ago

Cytori bags Azaya drugs in asset purchase; Woodford offers a mea culpa on Northwest Bio

9 years ago

GSK R&D vet Russo jumps to Genenta, takes a lead role in developing a new gene therapy

9 years ago

Mallinckrodt just got its hand slapped for illegally protecting an 85,000% price hike

9 years ago

Anthrax-targeted biodefense biotechs join forces in merger pact

9 years ago

Shire finally finishes a 10-year trek back to the FDA with an old ADHD drug

9 years ago

Dermira sweeps PhIII psoriasis studies for Cimzia as rivals threaten another entry

9 years ago

First page Previous page 1143 1144 114511461147 1148 1149 Next page Last page